All News

Polycythemia Vera | Image credit: Elizabeth L. Courville, MD, for ASH Image Bank

Experts are asking whether the study and treatment of myeloproliferative neoplasms (MPNs) is ready for a new era with new end points, with data that show how survival benefits are biologically linked to changes in the spleen, reduction in fibrosis, or other responses.